SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-23-003305
Filing Date
2023-03-08
Accepted
2023-03-08 16:05:50
Documents
4
Period of Report
2023-03-08

Document Format Files

Seq Description Document Type Size
1 6-K cyad-6k_20230308.htm 6-K 25501
2 EX-99.1 cyad-ex991_14.htm EX-99.1 25910
3 GRAPHIC gqyzkevhcqkm000003.jpg GRAPHIC 12636
4 GRAPHIC gqyzkevhcqkm000001.jpg GRAPHIC 18366
  Complete submission text file 0001564590-23-003305.txt   95586
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 23716155
SIC: 2834 Pharmaceutical Preparations